Indications for Use
The primary indication for nifurtimox is New World trypanosomiasis (Chagas disease). This condition is caused by the protozoan parasite Trypanosoma cruzi and requires specific etiotropic therapy to prevent severe organ damage.
Biochemical Mechanism of Action
The pharmacological effect of the drug is based on inducing oxidative stress inside the pathogen's cell:
- Upon entering the parasite, the drug is metabolized into nitroaromatic radicals.
- These generated radicals react to form superoxide anion radicals.
- Subsequent interaction with water synthesizes cytotoxic hydrogen peroxide ($H_2O_2$), which is lethal to the pathogen.
Basis of Therapeutic Selectivity
The selective toxicity of the drug is explained by differences in antioxidant defense systems:
- Trypanosoma cruzi completely lacks catalase and enzymes capable of degrading peroxides, making the parasite highly vulnerable to nitroaromatic compounds.
- Mammalian host cells are well-protected by their own antioxidant defense enzymes, including catalase, glutathione peroxidase, and superoxide dismutase.
Adverse Reactions
Administration of the drug is accompanied by several adverse effects involving the nervous system and the gastrointestinal tract. Patients may experience anorexia and vomiting, alongside neurological complications such as sleep disorders, memory impairment, and seizures.